title: Maintaining residual kidney function in dialysis patients-is there a role for angiotensin-converting enzyme inhibitors or angiotensin receptor blockers?
authors.affiliation: Royal Free Hospital, London, England. Electronic address: andrewdavenport@nhs.net.
authors.forename: Andrew
authors.initials: A
authors.lastname: Davenport
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D000809:Angiotensins / Q000037:antagonists & inhibitors*; D018450:Disease Progression; D005260:Female; D006801:Humans; D007668:Kidney / Q000502:physiology*; D008297:Male; D006435:Renal Dialysis / Q000639:trends*; D051436:Renal Insufficiency, Chronic / Q000628:therapy*
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000809:Angiotensins